This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lim, E. H. Articles by Tan, P. Search for Related Content PubMed PubMed Citation Articles by Lim, E. H. Articles by Tan, P.

Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers

¹ National University Hospital and
² National Cancer Centre of Singapore, Singapore

Purpose: The majority of patients with non-small cell lung cancer (NSCLC) present at an advanced clinical stage, when surgery is not a recommended therapeutic option. In such cases, tissues for molecular research are usually limited to the low-volume samples obtained at the time of diagnosis, usually via fine-needle aspiration (FNA). We tested the feasibility of performing gene expression profiling of advanced NSCLCs using amplified RNA from lung FNAs.

Experimental Design and Results: A total of 46 FNAs was tested, of which 18 yielded RNA of sufficient quality for microarray analysis. Expression profiles of these 18 samples were compared with profiles of 17 pairs of tumor and normal lung tissues that had been surgically obtained. Using a variety of unsupervised and supervised analytical approaches, we found that the FNA profiles were highly distinct from the normal samples and similar to the tumor profiles.

Conclusions: We conclude that when RNA amplification is successful, gene expression profiles from NSCLC FNAs can determine malignancy and suggest that with additional refinement and standardization of sample collection and RNA amplification protocols, it will be possible to conduct additional and more detailed molecular analysis of advanced NSCLC using lung FNAs.

This article has been cited by other articles:

				A. E. Szafranska, M. Doleshal, H. S. Edmunds, S. Gordon, J. Luttges, J. B. Munding, R. J. Barth Jr, E. J. Gutmann, A. A. Suriawinata, J. Marc Pipas, et al. Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues Clin. Chem., October 1, 2008; 54(10): 1716 - 1724. [Abstract] [Full Text] [PDF]

				J. M. Amann, P. Chaurand, A. Gonzalez, J. A. Mobley, P. P. Massion, D. P. Carbone, and R. M. Caprioli Selective Profiling of Proteins in Lung Cancer Cells from Fine-Needle Aspirates by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Clin. Cancer Res., September 1, 2006; 12(17): 5142 - 5150. [Abstract] [Full Text] [PDF]

				G Kocjan BEST PRACTICE No 185 Cytological and molecular diagnosis of lymphoma J. Clin. Pathol., June 1, 2005; 58(6): 561 - 567. [Abstract] [Full Text] [PDF]

				C. A. Granville and P. A. Dennis An Overview of Lung Cancer Genomics and Proteomics Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 169 - 176. [Abstract] [Full Text] [PDF]

				A. C. Borczuk, L. Shah, G. D. N. Pearson, K. L. Walter, L. Wang, J. H. M. Austin, R. A. Friedman, and C. A. Powell Molecular Signatures in Biopsy Specimens of Lung Cancer Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 167 - 174. [Abstract] [Full Text] [PDF]

				R. D. Petty, M. C. Nicolson, K. M. Kerr, E. Collie-Duguid, and G. I. Murray Gene Expression Profiling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application Clin. Cancer Res., May 15, 2004; 10(10): 3237 - 3248. [Abstract] [Full Text] [PDF]